Pharmacist counseling is cost-effective and can contribute to improved adherence.
By improving medication adherence and generic drug use, the United States healthcare system could save $20 billion in medical costs, according to CVS Caremark’s 2013 State of the States: Medication Adherence Report.
The second-annual report projects potential cost-savings for each state by examining medication adherence rates and the use of generic drugs for diabetes, hypertension (high blood pressure), dyslipidemia (high cholesterol) and depression. Based on state member characteristics, potential cost-savings among states range from $19 million to $2.1 billion.
The report also examines three market segments: health plans, employer-sponsored plans and Medicare Part D prescription drug plans. An interactive hub allows viewers to filter data based on market segment, health condition and adherence measure to gain insight into a specific state or draw comparisons among them.
The report also found that $13.4 billion could be saved if patients switched from expensive brands to generics. Another $6.5 billion could be saved if patients picked up their prescriptions 80% of the time.
While the report focuses on state-specific data, results reflected some important trends in medication adherence nationwide.
Across all market segments, patients with depression had the lowest adherence rates, while patients with hypertension were most adherent. Medicare beneficiaries had the highest adherence rates across all three groups.
The Midwest had the lowest adherence rates for health plan members with diabetes and depression, while the South had the lowest rates for patients with any condition in employer-sponsored plans and Medicare Part D.
Medication nonadherence in the United States already accounts for up to $290 billion annually in excess healthcare costs, according to the New England Healthcare Institute. Research shows that interventions such as pharmacist counseling are cost-effective and contribute to improved adherence, showing that pharmacists and other healthcare professionals can help patients effectively manage chronic diseases.
The CVS Caremark Pharmacy Advisor counseling program has been shown to increase adherence rates up to 3.9% and return $3 in savings for every $1 on counseling. In a multi-year collaboration with Brigham and Women’s Hospital, CVS Caremark has worked to research pharmacy claims data in order to better understand what influences medication adherence.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More